207 related articles for article (PubMed ID: 8004820)
1. Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody.
Hosaka N; Nagata N; Miyashima S; Ikehara S
Clin Exp Immunol; 1994 Jun; 96(3):500-7. PubMed ID: 8004820
[TBL] [Abstract][Full Text] [Related]
2. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
3. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
Nagata N; Nakagawa T; Hosaka N; Ikehara S
Immunobiology; 1992 Nov; 186(5):339-50. PubMed ID: 1286875
[TBL] [Abstract][Full Text] [Related]
4. MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.
Ashany D; Hines JJ; Gharavi AE; Mouradian J; Drappa J; Elkon KB
Clin Exp Immunol; 1992 Dec; 90(3):466-75. PubMed ID: 1458684
[TBL] [Abstract][Full Text] [Related]
5. Comparison of wasting syndrome in [MRL lpr/lpr-->MRL +/+] chimera and graft versus host disease in [B10.D2-->BALB/c] chimera and an attempt to transfer the wasting syndrome in [MRL lpr/lpr-->MRL +/+] to MRL +/+ mice.
Aihara M; Aihara Y; Nakajima H
J Dermatol Sci; 1994 Apr; 7(2):107-18. PubMed ID: 7914743
[TBL] [Abstract][Full Text] [Related]
6. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
7. Analyses of lpr-GVHD by adoptive transfer experiments using MRL/lpr-Thy-1.1 congenic mice.
Hosaka N; Nagata N; Nakagawa T; Miyashima S; Yasumizu R; Ikehara S
Autoimmunity; 1994; 17(3):217-24. PubMed ID: 7948606
[TBL] [Abstract][Full Text] [Related]
8. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
9. Auto-MHC class II-reactive T cell line obtained from MRL/+mice suffering from "lpr-GVHD". I. Characterization of surface phenotypes, specificities and functions in vitro.
Nagata N; Yasumizu R; Ohnishi Y; Nakagawa T; Inaba M; Ikehara S
Immunobiology; 1990 Nov; 181(4-5):367-78. PubMed ID: 2099906
[TBL] [Abstract][Full Text] [Related]
10. Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer.
Fraziano M; Montesano C; Sammarco I; di Cesare S; Caroleo MC; Mattei M; Cannata S; Poccia F; Bellavia A; Salerno A
Clin Immunol Immunopathol; 1994 Jun; 71(3):265-72. PubMed ID: 8200130
[TBL] [Abstract][Full Text] [Related]
11. Increased cell surface expression of a newly identified heterodimer on activated blastic T cells.
Nagata N; Taketani S; Nakagawa T; Hosaka N; Hisha H; Tokunaga R; Ikehara S
Cell Immunol; 1994 Feb; 153(2):516-26. PubMed ID: 8118879
[TBL] [Abstract][Full Text] [Related]
12. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
Mountz JD; Smith TM; Toth KS
J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
[TBL] [Abstract][Full Text] [Related]
14. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
15. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
[TBL] [Abstract][Full Text] [Related]
16. An allogeneic microenvironment influences the phenotype of intermediate T-cell receptor cells expanding in MRL-lpr/lpr mice.
Tsukahara A; Iiai T; Moroda T; Tada T; Suzuki S; Takeda K; Hatakeyama K; Abo T
Immunology; 1998 Jun; 94(2):149-59. PubMed ID: 9741335
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
[TBL] [Abstract][Full Text] [Related]
18. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
19. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
20. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells.
Iwai H; Tomoda K; Hosaka N; Miyashima S; Suzuka Y; Ikeda H; Lee S; Inaba M; Ikehara S; Yamashita T
Hear Res; 1998 Mar; 117(1-2):173-7. PubMed ID: 9557987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
